Results 81 to 90 of about 1,777 (209)
New insights into NPP1 function:Lessons from clinical and animal studies [PDF]
The recent elucidation of rare human genetic disorders resulting from mutations in ectonucleotide pyrophosphotase/phosphodiesterase (ENPP1), also known as plasma cell membrane glycoprotein 1 (PC-1), has highlighted the vital importance of this molecule ...
Huesa, C +3 more
core +1 more source
PURPOSE: To modify the Performance-Oriented Mobility Assessment-Gait (POMA-G) subtest and validate this modified POMA-G (mPOMA-G) in children with hypophosphatasia (HPP), a rare metabolic disorder that can manifest with musculoskeletal symptoms that ...
Dawn Phillips +7 more
doaj +1 more source
Managing the patient with osteogenesis imperfecta: a multidisciplinary approach [PDF]
Osteogenesis imperfecta (OI) is a heterogeneous heritable connective tissue disorder characterized by low bone density. The type and severity of OI are variable.
Bishop, N., Marr, C., Seasman, A.
core +1 more source
Genome sequencing helped find answers for 1 in 5 children with rare conditions in an outpatient study looking at hybrid genetic care delivery. Families who chose testing themselves had the highest diagnostic yield, showing that self‐referral may be a helpful way to improve access to genetic care.
Kristin Theobald +10 more
wiley +1 more source
Objective Hypophosphatasia (HPP) is an inherited disorder of defective skeletal mineralization caused by mutations in the ALPL gene that encodes the Tissue Non-specific Alkaline Phosphatase (TNSALP).
Xiaojian Mao +12 more
doaj +1 more source
A systematic review and meta-analysis of childhood health utilities [PDF]
Background: A common feature of most reviews or catalogues of health utilities has been their focus on adult health states or derivation of values from adult populations.
Kim, Sung Wook +5 more
core +1 more source
Using male and female tissue‐nonspecific alkaline phosphatase (TNAP) knockout (KO) and wild type (WT) mice, we show TNAP loss impairs growth and sensorimotor function and induces marked microglial morphological changes (enlarged soma, retracted processes).
Kareem Elaswad +5 more
wiley +1 more source
Hypophosphatasia (HPP) is a rare inherited metabolic disorder predominantly affecting bones and teeth. HPP can manifest throughout the life cycle from in utero, to perinatal and infantile (before 6 months of age) presentations, to onset in childhood ...
Abhay Srivastava +3 more
doaj +1 more source
Background Hypophosphatasia (HPP) is a rare, inherited metabolic disorder caused by loss-of-function mutations in the ALPL gene that encodes the tissue-nonspecific alkaline phosphatase TNAP (ORPHA 436).
Marius Vogt +7 more
doaj +1 more source
Outlook Magazine, Fall 2002 [PDF]
https://digitalcommons.wustl.edu/outlook/1147/thumbnail ...
core +1 more source

